High prevalence of fluoroquinolone-resistant group b streptococci among clinical isolates in china and predominance of sequence type 19 with serotype III

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1538-1541

  Wang, Hui ^a   Zhao, Chunjiang ^a   He, Wenqiang ^a   Zhang, Feifei ^a   Zhang, Liyan ^b   Cao, Bin ^c   Sun, Ziyong ^d   Xu, Yingchun ^e   Yang, Qing ^f   Mei, Yaning ^g   Hu, Bijie ^h   Chu, Yunzhuo ⁱ   Liao, Kang ^j   Yu, Yunsong ^k   Hu, Zhidong ^l   Ni, Yuxing ^m  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^f ZHEJIANG UNIVERSITY   (China)

^g NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^h FUDAN UNIVERSITY   (China)

ⁱ CHINA MEDICAL UNIVERSITY   (China)

^j THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^k ZHEJIANG UNIVERSITY   (China)

^l TIANJIN MEDICAL UNIVERSITY   (China)

^m SHANGHAI JIAO TONG UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ADULT; AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHINA; CLINDAMYCIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; MIDDLE AGED; MUTATION; OFLOXACIN; PREVALENCE; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TETRACYCLINE;

EID: 84874039464     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02317-12     Document Type: Article

References (30)

1. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. 2009. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin. Infect. Dis. 49:85-92.
2. Rocchetti T, Marconi C, Rall V, Borges V, Corrente J, da Silva M. 2011. Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora. Arch. Gynecol. Obstet. 283:717-721.
3. Neugut AI, Ghatak AT, Miller RL. 2001. Anaphylaxis in the united states: an investigation into its epidemiology. Arch. Intern. Med. 161:15-21.
4. Miro E, Rebollo M, Rivera A, Alvarez MT, Navarro F, Mirelis B, Coll P. 2006. Streptococcus agalactiae highly resistant to fluoroquinolones. Enferm. Infecc. Microbiol. Clin. 24:562-563.
5. Wu H-M, Janapatla RP, Ho Y-R, Hung K-H, Wu C-W, Yan J-J, Wu J-J. 2008. Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob. Agents Chemother. 52:1888 -1890.
6. Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y. 2012. Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J. Antimicrob. Chemother. 67:849-856.
7. Ecker KL, Donohue PK, Kim KS, Shepard JA, Aucott SW. 2012. The impact of group B streptococcus prophylaxis on late-onset neonatal infections. J. Perinatol. [Epub ahead of print.] doi:10.1038/jp.2012.76.
8. Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. 2010. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J. Microbiol. Methods 80:212- 214.
9. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056 -2065.
10. van der Mee-Marquet N, Jouannet C, Domelier A-S, Arnault L, Lartigue M-F, Quentin R. 2009. Genetic diversity of Streptococcus agalactiae strains and density of vaginal carriage. J. Med. Microbiol. 58:169 -173.
11. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard-eighth edition. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Tazi A, Gueudet T, Varon E, Gilly L, Trieu-Cuot P, Poyart C. 2008. Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg. Infect. Dis. 14:349 -350.
14. Ng LK, Martin I, Alfa M, Mulvey M. 2001. Multiplex PCR for the detection of tetracycline resistant genes. Mol. Cell. Probes 15:209 -215.
15. Oster P, Zanchi A, Cresti S, Lattanzi M, Montagnani F, Cellesi C, Rossolini GM. 1999. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:2510 -2512.
16. Palmeiro JK, Dalla-Costa LM, Fracalanzza SEL, Botelho ACN, da Silva Nogueira K, Scheffer MC, de Almeida Torres RSL, de Carvalho NS, Cogo LL, Madeira HMF. 2010. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J. Clin. Microbiol. 48:4397- 4403.
17. Benson JA, Ferrieri P. 2001. Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J. Clin. Microbiol. 39:3006- 3008.
18. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Glaser P, Rusniok C, Crook DW, Harding RM, Bisharat N, Spratt BG. 2003. Multilocus sequence typing system for group B streptococcus. J. Clin. Microbiol. 41:2530 -2536.
19. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
20. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R. 2007. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J. Clin. Microbiol. 45:2909- 2916.
21. Sadowy E, Matynia B, Hryniewicz W. 2010. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J. Antimicrob. Chemother. 65:1907-1914.
22. Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, Sunakawa K, Ubukata K, the SDW Group. 2009. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother. 53:2650 -2653.
23. Martins ER, Melo-Cristino J, Ramirez M, Portuguese Group for the Study of Streptococcal Infections. 2012. Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal. J. Clin. Microbiol. 50:1219 -1227.
24. Martins ER, Andreu A, Correia P, Juncosa T, Bosch J, Ramirez M, Melo-Cristino J. 2011. Group B streptococci causing neonatal infections in Barcelona are a stable clonal population: 18-year surveillance. J. Clin. Microbiol. 49:2911-2918.
25. Wang Y-H, Su L-H, Hou J-N, Yang T-H, Lin T-Y, Chu C, Chiu C-H. 2010. Group B Streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008. J. Clin. Microbiol. 48:2571-2574.
26. Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, Itoh Y, Ezaki T. 2003. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Chemother. 47:3605-3609.
27. Biedenbach DJ, Toleman MA, Walsh TR, Jones RN. 2006. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone- resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997- 2004). Diagn. Microbiol. Infect. Dis. 55:119 -127.
28. Wehbeh W, Rojas-Diaz R, Li X, Mariano N, Grenner L, Segal-Maurer S, Tommasulo B, Drlica K, Urban C, Rahal JJ. 2005. Fluoroquinoloneresistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob. Agents Chemother. 49:2495-2497.
29. Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. 2009. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J. Clin. Microbiol. 47:1143-1148.
30. Manning SD, Lewis MA, Springman AC, Lehotzky E, Whittam TS, Davies D. 2008. Genotypic diversity and serotype distribution of group B streptococcus isolated from women before and after delivery. Clin. Infect. Dis. 46:1829 -1837.